Press Releases September 2, 2026 04:05 PM

Amwell® to participate in upcoming investor conferences

Amwell announces participation in major upcoming investor healthcare conferences

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
AMWL

Amwell (NYSE: AMWL), a leader in technology-enabled healthcare platforms, announced that its CFO and COO Mark Hirschhorn will represent the company at two prestigious investor conferences in September 2026. These events include the Wells Fargo 21st Annual Healthcare Conference and the Morgan Stanley 24th Annual Global Healthcare Conference, where the company will also host a fireside chat. Details for audio webcasts will be available on Amwell's investor relations website.

Amwell® to participate in upcoming investor conferences
AMWL
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Amwell will present and participate at two major healthcare investor conferences in September 2026.
  • CFO and COO Mark Hirschhorn will lead the company's investor engagement efforts at these events, including a fireside chat at Morgan Stanley's conference.
  • Amwell continues to highlight its comprehensive, technology-enabled care platform which supports health plans and healthcare organizations with integrated clinical programs.
  • The conferences focus on healthcare and technology sectors, reflecting Amwell’s role in digital health and telemedicine markets.

BOSTON, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology enabled care, today announced that members of the Amwell management team will participate in the following upcoming investor conferences:

  • Wells Fargo 21st Annual Healthcare Conference, on Wednesday, September 9, 2026, in Boston, MA. Mark Hirschhorn, CFO and COO, will represent the Company.
  • Morgan Stanley 24th Annual Global Healthcare Conference, on Wednesday, September 16, 2026, along with an in-person fireside chat from 1:05 p.m. to 1:40 p.m. ET, in New York, NY. Mark Hirschhorn, CFO and COO, will represent the Company.

Details regarding audio webcasts, where available, will be posted on the Company's investor relations website at https://investors.amwell.com.

About Amwell

Amwell offers health plans and healthcare organizations a single, comprehensive, technology-enabled care platform. We use technology to provide consumers with better access to more convenient, affordable, and effective care. The Amwell Platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows consumers to experience unified, personalized, and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell Platform is proven, operating at a large scale, enabling care for millions while delivering dependable outcomes. For two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.

Media Contact

Press inquiries:
[email protected]

Investor contact:
Asher Dewhurst
[email protected]


Risks

  • Investor conferences do not guarantee positive market response; company performance and market conditions remain uncertain.
  • Dependence on continued adoption of technology-enabled care platforms poses risks if healthcare providers or consumers shift preferences.
  • Competition and regulatory changes in healthcare technology and telemedicine markets could impact Amwell's growth and profitability.

More from Press Releases

Roivant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on Tuesday, September 8, 2026, and Host Investor Call Sep 6, 2026 Verizon Waives Charges for Hurricane Lowell, Prepares Network in Hawai'i Sep 5, 2026 Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen Sep 4, 2026 Grupo Aeroportuario del Pacifico Reports a Passenger Traffic Increase in August 2026 of 0.5% Compared to 2025 Sep 4, 2026 Schedule update: Stryker to participate in the 2026 Wells Fargo Healthcare Conference Sep 4, 2026